Beth Riggs on Muck Rack

Beth Riggs

Washington, D.C.
As seen in: International Business Times (U.S.), GlobeNewswire, Medical Xpress, KTLA-TV (Los Angeles, CA), Morningstar, The San Diego Union-Tribune, KDVR-TV (Denver, CO), KRON-TV (San Francisco, CA), WJW-TV (Cleveland, OH), ADVFN and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Beth

Contact Beth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

New T‑cell therapy targets three tumor proteins, shows early survival gains in aggressive pediatric brain cancers

|
By Beth Riggs, Stephanie Baum, Robert Egan Verified
| Medical Xpress Verified
Credit: Anna Shvets from Pexels Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors, including diffuse intrinsic pontine glioma (DIPG) and relapsed central nervous system (CNS) tumors.
Open in Who Shared View Duplicates (5) Issue with article?

First clinical trial of vosoritide for children with Original

|
By Beth Riggs
| GlobeNewswire
WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- Vosoritide’s first global phase 2 study showed an average increased growth rate of 1.8 cm per year in children with hypochondroplasia, a genetic cause of short stature in children, according to researchers from Children’s National Hospital. “This is the first medicine that has been developed to specifically target the pathway involved in hypochondroplasia,” says Andrew Dauber, M.D., chief of Endocrinology at Children’s National.
Open in Who Shared View Duplicates (229) Issue with article?
See all 124 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified